Cancer Council NSW funding kickstarts research into colorectal cancer, breast cancer and osteosarcoma
Cancer Council NSW Project Grant Recipients
02 March 2017
The Garvan Institute of Medical Research congratulates Dr Maya Kansara, Associate Professor Maija Kohonen-Corish, Associate Professor Elgene Lim, Dr Samantha Oakes, Professor Chris Ormandy and Associate Professor Alex Swarbrick, all of whom have received 2017 Project Grants from Cancer Council NSW.
The funding provides support over a three-year time period. The researchers will use their Project Grants to support groundbreaking research projects in breast cancer, colorectal cancer and osteosarcoma. Each project focuses on identifying new approaches to treating the cancer in question – from immunotherapies to target the rare cancer osteosarcoma, to targeting a ‘life and death’ switch protein in breast cancer.
The full list of Garvan awardees is as follows:
A/Prof Alexander Swarbrick: Exploring whether tiny molecules, called micro RNAS, can be targeted to improve breast cancer treatment;
Dr Samantha Oakes and Prof Christopher Ormandy: Treating a deadly form of breast cancer by turning off the cancer ‘life and death’ switch;
Dr Maya Kansara: Identifying new ways of targeting the immune system to treat osteosarcomas;
A/Prof Elgene Lim: Studying how well a new treatment combination can stop breast cancer growth and improve patient outcomes;
Prof Maija Kohonen-Corish: Identifying the molecular drivers of colorectal cancer so that targeted therapies can be developed.
The 15 successful Project Grant recipients were announced last night at Cancer Council NSW’s annual Research Awards, this year held in the evening of 1 March at Westpac’s Barangaroo tower in Sydney.
Read the full media release from Cancer Council NSW, including the list of all 15 Project Grant recipients.
Read a profile of Dr Alex Swarbrick that discusses his Cancer Council NSW funding.